Traditionally, monkeypox infections were rare in the United States. Recent reports, however, suggest that an unusual outbreak of monkeypox has occurred in several nations. Efforts must be made to curb the spread of this virus in order to prevent another pandemic. A proactive approach to medical management will not only help stop the outbreak, but will also help determine its extent.
Opinion article: a new international outbreak of smallpox. Image Credit: Geo / Shutterstock Comet
The smallpox virus is a member of the same virus family as the smallpox virus. It is a double-stranded deoxyribonucleic acid (DNA) virus that was first discovered in monkeys during the 1950s. This virus infects a wide range of hosts, including rodents. The smallpox eradication campaign uncovered human infestations. The Congo Basin clade is more virulent compared to the West African clade, which is a softer variant. The latter has been implicated in most cases of this smallpox outbreak.
The outbreak currently covers Australia, Austria, Belgium, Canada, the Czech Republic, Denmark, England, Finland, France, Germany, Israel, Italy, the Netherlands, Portugal, Scotland, Slovenia, Spain, Sweden, Switzerland, the United Arab Emirates and the United States. USA, reporting confirmed cases of monkeypox. This virus spreads in a pattern that does not resemble past outbreaks beyond Africa.
Outbreaks of smallpox have been identified in 11 African countries in recent years; most occurred in the Democratic Republic of the Congo. This increase in the number of cases was attributed to a decrease in the immunity of smallpox populations. The children formed a significant group among individuals who showed symptoms of monkeypox in Africa.
Monkeypox virus was first detected on other continents only after 2003. This viral spread can be caused by direct contact, respiratory drops, or fomites. The incubation period is 5-21 days, after which the symptoms begin along with the risk of transmission. Evidence of person-to-person transmission is scarce; therefore, reports of small outbreaks passed isolated among humans.
However, the Centers for Disease Control and Prevention (CDC), which has also recommended airborne infection control measures, has predicted airborne transmission. Infection control protocols emphasize the use of N95 masks and personal protective equipment for healthcare professionals and the general public when visiting public places.
Complications associated with monkeypox are: central nervous system (CNS) involvement and airway involvement due to lymphadenitis. The mortality rate can be between 1 and 10%, lower in regions with advanced health care facilities.
Remarkable outbreaks of monkeypox
The most notable outbreak was in the United States in 2003, when it spread from imported African rats to prairie dogs and then to humans. Of the four dozen documented cases, three people developed serious illnesses while there were no fatalities. There is a potential link between all human cases and infected animals. In response, prophylactic applications of the smallpox vaccine were recommended.
The last two decades have seen a considerable influx of smallpox from monkeys through international travelers exposed to the virus in endemic countries. The United States reported two travel-related cases in 2021, but no secondary spread.
Diagnosis of monkeypox
During the current outbreak, any new episodes of fever and rash should be suspected of monkeypox, especially in patients with lymphadenopathy.
The rash usually occurs first in the mouth, then spreads to the face and limbs, with a centrifugal distribution. Polymerase chain reaction (PCR) test of skin lesions or fluid is a confirmation of this infection.
Treatment of monkeypox
A standard of care for monkeypox has not yet been specified. Smallpox antivirals, such as cidofovir, brincidofovir, and tecovirimat, may be an effective modality. Brincidofovir and Tecovirimate are drugs approved by the US Food and Drug Administration (FDA) for smallpox. These agents should be reserved for the management of cases of severe smallpox and for the treatment of immunocompromised individuals.
Prevention of monkeypox
Smallpox vaccines have been shown to be effective in the prevention of smallpox and as a measure of post-exposure prophylaxis. Therefore, the FDA has suggested that the next generation smallpox vaccine, JYNNEOS (North Bavarian), can be used to prevent monkeypox. In addition, off-label use of ACAM2000, the small-generation smallpox vaccine, is also an option.
Experience with past outbreaks reminds us that vaccinating the infected person’s close contacts can help limit the transmission of monkeypox. In addition, prophylactic vaccines given immediately after possible exposure can significantly attenuate and even abort. Vaccinia immunoglobulin may serve as an alternative post-exposure prophylactic measure for people with contraindications to the smallpox vaccine.
The current outbreak
Dozens of cases of smallpox have been reported in Europe, the United Kingdom and North America, all outside the endemic areas. During the current outbreak, most of these countries have documented person-to-person transmissions in unrelated groups that cannot be traced back to endemic country travel. Thus, undetected transmission chains are now evident.
In addition, a considerable proportion of cases have been identified in homosexual men. This virus, however, is not only sexually transmitted; it is also likely to infest other humans after skin-to-skin contact or when exposed to an infected person’s respiratory drops.
Developing the epidemiology of monkeypox that has precipitated the current outbreak remains a challenge and may be of global relevance to explain the emergence of new pathogens. A deeper understanding of the cause of this outbreak, which has spread geographically beyond previous smallpox outbreaks in humans, is urgently needed. Findings like these can prevent similar microbial outbreaks in the future.
Genetic analysis does not delineate viral mutations as the reason for increased transmissibility. There has been a lot of random speculation in this regard, for example, spread through human groups and social networks. Case investigations and case studies and controls could help to understand the emergence of the broader scope of the monkeypox virus in the current scenario.
In the meantime, viral containment protocols should be implemented, which may include: case-finding, isolation, contact tracing, preventive measures, and close contact vaccination, and post-exposure vaccination. Healthcare professionals, especially those in primary care, are the most exposed to smallpox in monkeys and have more opportunities to identify new cases.
Source:
Magazine reference: